Skip to main content

Living diagnostics

The blog that connects you with the in vitro diagnostic world.

Bone and joint infections are complicated by antimicrobial resistance

Osteomyelitis – infection of the bone, and septic arthritis – joint infection, are serious medical conditions that can significantly impact a patient's quality of life. Bone and joint infections, often referred to as (BJIs), are notoriously difficult to treat and successful therapy requires organism-specific antimicrobial therapy at high doses for a prolonged duration.1 Diagnostics can support the identification and management of BJIs, while helping slow the progression of antimicrobial resistance (AMR).
Read more

Latest articles

Swipe for more articles

  • January 08, 2025

    What’s next in food safety? Key trends for 2025 and beyond

    At bioMérieux, we proudly operate at the forefront of diagnostics, supporting customers across the food and drinks industry to help protect consumers and strive for the very highest standards of safety and quality. As we enter 2025, we reflect on the trends we can expect to see in this important sector this year.
  • December 19, 2024

    Celebrating Innovation with Professor Ding: A Pioneer in Sustainable Endotoxin Testing

    A world-renowned pioneer in the field of molecular biotechnology and currently Emeritus Professor at the Department of Biological Sciences, National University of Singapore (NUS), Professor Jeak Ling Ding’s research focuses on innate immunity in host-pathogen interaction, antimicrobial defense and anticancer immunomodulation. Her work has resulted in around 300 scientific publications and patents, along with a host of awards and honors, including most recently her induction into the Singapore Women’s Hall of Fame. We spoke with Professor Ding to learn more about her career defining breakthrough to genetically engineer recombinant Factor C, and the importance of creating a sustainable and ethical alternative to replace traditional methods of endotoxin testing.
  • December 04, 2024

    Why participatory approaches for AMR matters to people and patient-centered action

    Antimicrobial Resistance (AMR) is a term that is not widely recognised by many people globally. What’s even more concerning is that those who are most affected by AMR—patients and their families—are often the ones who lack that awareness and rely on understanding its consequences.
  • November 20, 2024

    Advancing Antimicrobial Stewardship in Emergency Care: how diagnostics can change the game.

    Antimicrobial resistance (AMR) has been identified as an increasing threat to modern medicine, leading to higher treatment costs and increased morbidity and mortality.1 The misuse of broad-spectrum antibiotics is a major contributor to the rise of AMR — particularly in emergency care, where studies have estimated that 40% to 60% of antibiotics are inappropriately prescribed.2 To understand the cause of this disparity, it is important to provide context on the many unique facets of the emergency department, while exploring how comprehensive antimicrobial stewardship could improve prescribing practices.